Authors
Diane Ashiru-Oredope, Susan Hopkins on behalf of the English Surveillance Programme for Antimicrobial Utilization and Resistance Oversight Group, Anthony Kessel, Susan Hopkins, Diane Ashiru-Oredope, Brian Brown, Nicholas Brown, Sue Carter, Andre Charlett, Anna Cichowka, Sue Faulding, Rose Gallagher, Alan Johnson, Cliodna McNulty, Michael Moore, Bharat Patel, Richard Puleston, Colin Richman, Keith Ridge, Julie Robotham, Mike Sharland, Pete Stephens, Liz Stokle, Kate Towers, Jonathan Underhill, Tony West, Laura Whitney, Ailsa Wight, Neil Woodford, Tony Young
Publication date
2013/11/1
Journal
Journal of Antimicrobial Chemotherapy
Volume
68
Issue
11
Pages
2421-2423
Publisher
Oxford University Press
Description
The clinical, public health and economic implications of antimicrobial resistance present a major threat to future healthcare. Antimicrobial use is a major driver of resistance, and antimicrobial stewardship programmes are increasingly being advocated as a means of improving the quality of prescribing. However, to increase their impact and assess their success, a better understanding of antimicrobial usage, both in primary and secondary care, and linkage with antimicrobial resistance data are required. In England, national summaries of primary care dispensing data are issued annually by the Health and Social Care Information Centre. However, there is currently no routine public reporting of antimicrobial usage in hospitals. In response to the threat posed by antimicrobial resistance, as highlighted in the Report of the Chief Medical Officer and on the request of the Department of Health, Public Health England …
Total citations
20132014201520162017201820192020202120222023154883397510